Direct Oral Anticoagulants (DOACs) are a class of medication used to prevent and treat thromboembolic disorders by inhibiting specific clotting factors in the blood. They offer advantages over traditional anticoagulants like warfarin, including fewer dietary restrictions and no need for routine blood monitoring, but require careful management to avoid bleeding risks.